98 related articles for article (PubMed ID: 22173246)
1. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME - PART 2.
Goodman NF; Cobin RH; Futterweit W; Glueck JS; Legro RS; Carmina E; ; ;
Endocr Pract; 2015 Dec; 21(12):1415-26. PubMed ID: 26642102
[TBL] [Abstract][Full Text] [Related]
2. Association between polycystic ovary syndrome and metabolic syndrome.
Vélez LM; Motta AB
Curr Med Chem; 2014; 21(35):3999-4012. PubMed ID: 25245380
[TBL] [Abstract][Full Text] [Related]
3. The Global Epidemic of the Metabolic Syndrome.
Saklayen MG
Curr Hypertens Rep; 2018 Feb; 20(2):12. PubMed ID: 29480368
[TBL] [Abstract][Full Text] [Related]
4. Impact of metabolic syndrome on bone mineral density in men over 50 and postmenopausal women according to U.S. survey results.
Tan MY; Zhu SX; Wang GP; Liu ZX
Sci Rep; 2024 Mar; 14(1):7005. PubMed ID: 38523143
[TBL] [Abstract][Full Text] [Related]
5. Incidence of Thyroid Dysfunction Facing Metabolic Syndrome: A Prospective Comparative Study with 9 Years of Follow-Up.
Mehran L; Amouzegar A; Abdi H; Delbari N; Madreseh E; Tohidi M; Mansournia MA; Azizi F
Eur Thyroid J; 2021 Jul; 10(5):390-398. PubMed ID: 34540709
[TBL] [Abstract][Full Text] [Related]
6. Interventional Effects of Weight-Loss Policy in a Healthy City among Participants with Metabolic Syndrome.
Tai HC; Tzeng IS; Liang YC; Liao HH; Su CH; Kung WM
Int J Environ Res Public Health; 2019 Jan; 16(3):. PubMed ID: 30682780
[TBL] [Abstract][Full Text] [Related]
7. The Prevalence of Metabolic Syndrome In Non-alcoholic Fatty Liver Disease; A Population-Based Study.
Fattahi MR; Niknam R; Safarpour A; Sepehrimanesh M; Lotfi M
Middle East J Dig Dis; 2016 Apr; 8(2):131-7. PubMed ID: 27252820
[TBL] [Abstract][Full Text] [Related]
8. Iron Status and Metabolic Syndrome in Patients with Non-Alcoholic Fatty Liver Disease.
Ghamarchehreh ME; Jonaidi-Jafari N; Bigdeli M; Khedmat H; Saburi A
Middle East J Dig Dis; 2016 Jan; 8(1):31-8. PubMed ID: 26933479
[TBL] [Abstract][Full Text] [Related]
9. Effect of Low Glycemic Index Diet Versus Metformin on Metabolic Syndrome.
Rajabi S; Mazloom Z; Zamani A; Tabatabaee HR
Int J Endocrinol Metab; 2015 Oct; 13(4):e23091. PubMed ID: 26587028
[TBL] [Abstract][Full Text] [Related]
10. Oral supplementations with L-glutamine or L-alanyl-L-glutamine do not change metabolic alterations induced by long-term high-fat diet in the B6.129F2/J mouse model of insulin resistance.
Bock PM; Krause M; Schroeder HT; Hahn GF; Takahashi HK; Schöler CM; Nicoletti G; Neto LD; Rodrigues MI; Bruxel MA; Homem de Bittencourt PI
Mol Cell Biochem; 2016 Jan; 411(1-2):351-62. PubMed ID: 26530165
[TBL] [Abstract][Full Text] [Related]
11. The use of dietary supplements to alleviate androgen deprivation therapy side effects during prostate cancer treatment.
Dueregger A; Heidegger I; Ofer P; Perktold B; Ramoner R; Klocker H; Eder IE
Nutrients; 2014 Oct; 6(10):4491-519. PubMed ID: 25338271
[TBL] [Abstract][Full Text] [Related]
12. Correlation of obstructive sleep apnea hypopnea syndrome with metabolic syndrome in snorers.
Zhang Q; Zhang X; Zhao M; Huang H; Ding N; Zhang X; Wang H
J Biomed Res; 2014 May; 28(3):222-7. PubMed ID: 25013405
[TBL] [Abstract][Full Text] [Related]
13. Avocado oil supplementation modifies cardiovascular risk profile markers in a rat model of sucrose-induced metabolic changes.
Carvajal-Zarrabal O; Nolasco-Hipolito C; Aguilar-Uscanga MG; Melo-Santiesteban G; Hayward-Jones PM; Barradas-Dermitz DM
Dis Markers; 2014; 2014():386425. PubMed ID: 24719499
[TBL] [Abstract][Full Text] [Related]
14. Association of calcaneal quantitative ultrasound parameters with metabolic syndrome in middle-aged and elderly Chinese: a large population-based cross-sectional study.
Sun M; Cao M; Fu Q; Zhu Z; Meng C; Mao J; Shi Y; Duan Y; Tang W; Huang X; He W; Yang T
BMC Endocr Disord; 2014 Feb; 14():14. PubMed ID: 24529197
[TBL] [Abstract][Full Text] [Related]
15. Mitochondrial dysfunction: a basic mechanism in inflammation-related non-communicable diseases and therapeutic opportunities.
Hernández-Aguilera A; Rull A; Rodríguez-Gallego E; Riera-Borrull M; Luciano-Mateo F; Camps J; Menéndez JA; Joven J
Mediators Inflamm; 2013; 2013():135698. PubMed ID: 23533299
[TBL] [Abstract][Full Text] [Related]
16. A closer look at the role of urotensin II in the metabolic syndrome.
Barrette PO; Schwertani AG
Front Endocrinol (Lausanne); 2012; 3():165. PubMed ID: 23293629
[TBL] [Abstract][Full Text] [Related]
17. Establishment of Health Clinics as Mass Screening and Referral Systems for Chronic Non-communicable Diseases in Primary Health Care.
Heidari K; Sajjadi SA; Hadian R; Hadi S; Hosseinkhani R; Amini S; Kiani Z; Ajami A; Fadaei R; Shahriari A; Keramatian K
Int J Prev Med; 2012 Mar; 3(3):173-80. PubMed ID: 22448310
[TBL] [Abstract][Full Text] [Related]
18. Metabolic syndrome.
Cho LW
Singapore Med J; 2011 Nov; 52(11):779-85. PubMed ID: 22173246
[TBL] [Abstract][Full Text] [Related]
19. Comorbidities in polycystic ovary syndrome: their relationship to insulin resistance.
Bethea SW; Nestler JE
Panminerva Med; 2008 Dec; 50(4):295-304. PubMed ID: 19078870
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
